News
A fascinating look back at the potential 'Star Trek' sequel TV show includes some incredible imaginings of what the new USS ...
Kansas athletic director Travis Goff explained how David Booth’s donation gives the Jayhawks more confidence for phase two of ...
2d
GlobalData on MSNAligos commences dosing in Phase II trial for chronic hepatitis B treatment
The trial aims to compare the efficacy and safety of the therapy as a single agent with tenofovir disoproxil fumarate.
Q2 2025 Management View Jennifer S. Buell, President and CEO, stated that MiNK continues to be "the most clinically advanced company, industrializing off-the-shelf, invariant natural killer T cells." ...
In this randomized, double-blind trial, Aligos Therapeutics is evaluating its investigational oral capsid assembly modulator ALG-000184 against tenofovir disoproxil fumarate in 200 treatment-naïve ...
Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...
Results from the Phase II COLLECTiVE202 trial (NCT05370885) demonstrated a statistically significant difference between VE202 ...
Q2 2025 Management View CEO Thane Wettig highlighted three main priorities: the pending sale of FibroGen China, the ...
Seventeen patients with R/R MCL received a single dose of LV20.19 CAR T cells at 2.5 × 10 6 cells/kg (phase I = three patients; phase II = 14 patients). The best overall response rate (ORR) was 100% ...
Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...
Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy ...
UNESCO has officially launched Phase II of the Africa Asia Youth Coding Initiative, a transformative project that will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results